The state’s grossly unfair drugs policy is enough to make you sick

The state’s grossly unfair drugs policy is enough to make you sick

The government response to the CervicalCheck debacle means patients can only access the latest drugs if they have the ‘right’ illness

Picture this. You have endometrial cancer. The latest clinical trials show that a new drug called Keytruda, or Pembrolizumab, is generating some great results.

About 40 per cent of patients like you - with endometrial cancer - respond to ‘Pembro’ according to the latest trials, but the health service won’t fund it.

The health service is funding that drug for patients with cervical cancer, even though only 12 per cent of those patients respond.

Subscribe from just 1€

Exclusive offers

Choose the subscription that is right for you

Monthly Subscription

€1

For the first month

€19.99 Monthly Thereafter

Subscribe today

Cancel anytime

Annual Subscription

€200€149

For the first year

€199.99 annually thereafter

Subscribe today

Cancel anytime

Quarterly Subscription

€55€42

For the first 90 days

€55.00 quarterly Thereafter

Subscribe today

Cancel anytime

These offers are not available for current subscribers. Offers and pricing are subject to change without notice.

Terms & Conditions Apply

Please Subscribe or Log in to continue

Subscribe Login

Related Articles

More from The Business Post